文献速递心脑血管急症重症综合管理与镇静镇痛

急性心力衰竭合并快速房颤患者静脉使用地高辛与短期死亡率的关系:按年龄、肾功能和血清钾分析

Association of intravenous digoxin use in acute heart failure with rapid atrial fibrillation and short-term mortality according to patient age, renal function, and serum potassium.
PubMed 文献 · Eur J Emerg Med · 2024-07-08
一句话结论西班牙45家急诊科队列显示,急性心衰合并快速房颤患者急诊静脉使用地高辛与30天死亡率无显著相关,且不受年龄、肾功能或血钾影响。

该研究为西班牙EAHFE队列的二次分析,纳入45家急诊科2194例急性心衰合并快速房颤(心率≥100次/分)且家中未使用地高辛的患者,按急诊是否静脉使用地高辛分为两组(用药组864例,未用药组1330例)。30天随访死亡191例(8.9%),两组死亡率无差异(8.5% vs 9.1%,P=0.636)。限制性立方样条分析显示死亡与高龄、肾功能差及低钾/高钾相关,但静脉地高辛与这些关系均无交互作用(年龄P=0.156,eGFR P=0.156,血钾P=0.429)。结论认为急诊静脉使用地高辛与30天死亡率无显著改变,且不受年龄、肾功能或血钾异常影响。

要点

  • 急性心衰合并快速房颤(心率≥100次/分)患者中,急诊静脉使用地高辛组30天死亡率8.5%,未使用组9.1%,差异无统计学意义(P=0.636)。
  • 死亡与高龄、肾功能差、低钾血症和高钾血症相关,但静脉地高辛与年龄(P=0.156)、eGFR(P=0.156)、血钾(P=0.429)均无交互作用。
  • 该队列中位年龄82岁(IQR 76-87),61.4%为女性,65.2%有房颤病史,急诊到达时中位心率120次/分(IQR 109-135)。
  • 研究结论认为,无论患者年龄、是否存在肾功能不全或血清钾异常,静脉地高辛均未带来30天死亡率的显著变化。

适用人群与场景

  • 西班牙45家急诊科诊断为急性心衰并快速房颤(心率≥100次/分)的患者。
  • 家中未使用地高辛者。
  • 按急诊是否静脉使用地高辛分为用药组(864例,39.4%)和未用药组(1330例,60.6%)。

诊断标准与关键阈值

  • 快速房颤定义为心率≥100次/分。
  • 急性心衰由急诊诊断。

红旗征与不能漏的情况

  • 死亡与高龄、肾功能差、低钾血症和高钾血症相关(限制性立方样条分析)。

研究设计与关键结果

  • 研究类型为西班牙EAHFE队列的二次分析,纳入45家急诊科2194例急性心衰合并快速房颤且家中未使用地高辛的患者。
  • 患者中位年龄82岁(IQR 76-87),61.4%为女性,65.2%有既往房颤发作,急诊到达时中位心率120次/分(IQR 109-135)。
  • 30天随访期间死亡191例(8.9%),静脉地高辛组死亡率8.5%,未使用组9.1%,差异无统计学意义(P=0.636)。
  • 限制性立方样条分析(校正相关患者和发作变量)显示,死亡与高龄、肾功能较差、低钾血症和高钾血症相关。
  • 静脉地高辛与年龄(P=0.156)、eGFR(P=0.156)、血钾(P=0.429)的交互作用均无统计学意义。

证据类型、等级与局限

  • 证据类型:西班牙EAHFE队列的二次分析。
  • 局限:原文未报告局限性。

对床旁实践的改变

  • 作者认为,急诊静脉使用地高辛与30天死亡率无显著改变,且该结果不受患者年龄、肾功能不全或血清钾异常影响。

提炼说明

  • 本条依据论文摘要整理;摘要未涉及「处置流程与药物剂量」「指南或共识出处」,故未列出这些栏目;全文请点「阅读原文」。
英文原文(摘要)· 点击展开

BACKGROUND: Intravenous digoxin is still used in emergency departments (EDs) to treat patients with acute heart failure (AHF), especially in those with rapid atrial fibrillation. Nonetheless, many emergency physicians are reluctant to use intravenous digoxin in patients with advanced age, impaired renal function, and potassium disturbances due to its potential capacity to increase adverse outcomes.

OBJECTIVE: We investigated whether intravenous digoxin used to treat rapid atrial fibrillation in patients with AHF may influence mortality in patients with specific age, estimated glomerular filtration rate (eGFR), and serum potassium classes.

DESIGN: A secondary analysis of patients included in in the Spanish EAHFE cohort, which includes patients diagnosed with AHF in the ED.

SETTING: 45 Spanish EDs.

PARTICIPANTS: Two thousand one hundred ninety-four patients with AHF and rapid atrial fibrillation (heart rate ≥100 bpm) not receiving digoxin at home, divided according to whether they were or were not treated with intravenous digoxin in the ED.

OUTCOME: The relationships between age, eGFR, and potassium with 30-day mortality were investigated using restricted cubic spline (RCS) models adjusted for relevant patient and episode variables. The impact of digoxin use on such relationships was assessed by checking interaction.

MAIN RESULTS: The median age of the patients was 82 years [interquartile range (IQR) = 76-87], 61.4% were women, 65.2% had previous episodes of atrial fibrillation, and the median heart rate at ED arrival was 120 bpm (IQR = 109-135). Digoxin and no digoxin groups were formed by 864 (39.4%) and 1330 (60.6%) patients, respectively. There were 191 deaths within the 30-day follow-up period (8.9%), with no differences between patients receiving or not receiving digoxin (8.5 vs. 9.1%, P = 0.636). Although analysis of RCS curves showed that death was associated with advanced age, worse renal function, and hypo- and hyperkalemia, use of intravenous digoxin did not interact with any of these relationships ( P = 0.156 for age, P = 0.156 for eGFR; P = 0.429 for potassium).

CONCLUSION: The use of intravenous digoxin in the ED was not associated with significant changes in 30-day mortality, which was confirmed irrespective of patient age or the existence of renal dysfunction or serum potassium disturbances.

来源:Eur J Emerg Med,查看原文。版权归原作者所有。

参考来源

  1. Miró Ò, Martín Mojarro E, Lopez-Ayala P, et al. Association of intravenous digoxin use in acute heart failure with rapid atrial fibrillation and short-term mortality according to patient age, renal function, and serum potassium. Eur J Emerg Med. 2024. PMID: 38985840. doi:10.1097/MEJ.0000000000001153

供执业医师抢救与诊疗参考,不替代临床判断;剂量请结合体重、肝肾功能和本院药品规格复核,以指南原文为准。